• Publications
  • Influence
V79 survival following simultaneous or sequential irradiation by 15-MeV neutrons and 60Co photons.
A unique tandem source irradiation facility, composed of an intense d-T neutron source and a 60Co teletherapy unit, was used to investigate biological responses for different neutron/photonExpand
  • 47
  • 5
A consistent set of neutron kerma coefficients from thermal to 150 MeV for biologically important materials.
Neutron cross sections for nonelastic and elastic reactions on a range of elements have been evaluated for incident energies up to 150 MeV. These cross sections agree well with experimental crossExpand
  • 85
  • 3
Maximum proton kinetic energy and patient-generated neutron fluence considerations in proton beam arc delivery radiation therapy.
Several compact proton accelerator systems for use in proton therapy have recently been proposed. Of paramount importance to the development of such an accelerator system is the maximum kineticExpand
  • 18
  • 2
Longitudinal relaxation times of 129Xe in rat tissue homogenates at 9.4 T
Longitudinal relaxation times of 129Xe were measured in homogenates of rat brain, kidney, liver, and lung at varying oxygenation levels as a means to assess the feasibility of magnetic resonance (MR)Expand
  • 24
  • 2
Isoeffective dose: a concept for biological weighting of absorbed dose in proton and heavier-ion therapies.
When reporting radiation therapy procedures, International Commission on Radiation Units and Measurements (ICRU) recommends specifying absorbed dose at/in all clinically relevant points and/orExpand
  • 22
  • 2
Nuclear Data Needs for Neutron Therapy and Radiation Protection
New nuclear data are required for improved neutron and proton radiotherapy treatment planning as well as future applications of high energy particle accelerators. Modern neutron radiotherapy employsExpand
  • 22
  • 2
Survival of parenchymal hepatocytes irradiated with 14.3 MeV neutrons.
The purpose of these experiments was to estimate the RBE of neutrons for parenchymal hepatocytes as a function of neutron dose and to determine the ability of liver cells to repair potentially lethalExpand
  • 19
  • 1
A prototype beam delivery system for the proton medical accelerator at Loma Linda.
A variable energy proton accelerator was commissioned at Fermi National Accelerator Laboratory for use in cancer treatment at the Loma Linda University Medical Center. The advantages of precise doseExpand
  • 40
  • 1
The RBE issues in ion-beam therapy: conclusions of a joint IAEA/ICRU working group regarding quantities and units.
This paper summarises the conclusions of a working group established jointly by the International Atomic Energy Agency (IAEA) and the International Commission on Radiation Units and MeasurementsExpand
  • 37
  • 1